All News

2060 articles, sorted by publication time.

Precision Medicine · uk

Testing drugs on virtual tumors first: symbolic AI retrospectively predicts breast cancer response, with 74% agreement across 31 cases

Researchers used patients’ genetic data to build tumor “digital twins,” reproducing existing treatment responses and identifying potential drug options for those with incomplete responses. However, the improvements predicted by computer simulations still require validation in prospective clinical studies.

Cancer and Immunotherapy · global

Rectal cancer immunotherapy trial reports 76% complete response rate; surgery avoidance requires separate interpretation

AZUR-1 raises the possibility of organ preservation in rectal cancer with specific molecular features: investigators determined that 68% of evaluable patients maintained a clinical complete response for at least one year without surgery. However, the overall figure of 76% includes postoperative pathology results, and independent review data remain immature.

Cancer and Precision Medicine · uk

Should Treatment Be Intensified for High-Risk Prostate Cancer? Genomic Scores Offer Clues for Stratification

An analysis combining large-scale real-world data with 401 randomized trial participants suggests that Decipher scores may help identify which patients have a greater need for additional hormone therapy. However, independent validation is needed before the scores can be used to reduce medication use in patients with low scores.

Clinical Research · global

Can Preoperative Breast Cancer Treatment Use Less Chemotherapy? Antibody Combination Trial Highlights the Importance of Immune Subtyping

Combining two antibody drugs allowed some patients with immune-positive, high-risk early breast cancer to avoid subsequent conventional chemotherapy. But the overall strategy has yet to demonstrate superiority over the control regimen, and lung toxicity reminds researchers that reducing treatment burden must go hand in hand with maintaining efficacy and safety.